Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type

Table 1 Baseline characteristics of patients

Characteristics (n = 216)	Data
Age at transplant (range), yr	49.1 ± 7.7 (21-66)
Duration posttransplant (range), mo	49.1 ± 29.5 (6-178)
Male/Female (%)	158/58 (73/27)
Donor type (%)
LDLT	169 (78)
CDLT	47 (22)
Indication for transplant (%)
Hepatitis B cirrhosis	113 (52.3)
Hepatitis C cirrhosis	3 (1.4)
Alcoholic cirrhosis	8 (3.7)
Mixed type cirrhosis1	6 (2.8)
Cryptogenic cirrhosis	3 (1.4)
Hepatocellular carcinoma2	75 (34.7)
Autoimmune hepatitis	5 (2.3)
Wilson’s disease	1 (0.5)
Primary biliary cirrhosis	1 (0.5)
Child-Pugh score	9.5 ± 2.2 (5-14)
Cirrhosis complication3 (%)
Ascites	130 (60)
Variceal bleeding	53 (25)
Encephalopathy	81 (38)
SBP	24 (11)
Hepato-renal syndrome	4 (2)
Platelet count, pretransplant (× 103/μL)	58 ± 36 (9-340)
Platelet group (%)
Group 1 (< 30 000/μL)	29 (13)
Group 2 (30 000-50 000/μL)	80 (37)
Gourp 3 (50 000-100 000/μL)	88 (41)
Group 4 (≥ 100 000/μL)	19 (9)
Spleen volume, pretransplant (mm3, n = 193)	1105 ± 636 (128-4858)

¹Alcohol cirrhosis + hepatitis B cirrhosis (n = 5); hepatitis B cirrhosis + hepatitis C cirrhosis (n = 1);

²With hepatitis B virus (n = 70), hepatitis C virus (n = 5);

³Included overlap; SBP: Spontaneous bacterial peritonitis; LDLT: Living donor liver transplantation; CDLT: Cadaveric donor liver transplantation.